Accretion Pharmaceuticals P/E Ratio
Current P/E Ratio
16.94
Moderate Valuation
Moderate - Fairly valued
Accretion Pharmaceuticals (ACCPL) P/E ratio is 16.94 (Moderate), EPS (TTM) ₹8.48, current price ₹ on None — Moderate - Fairly valued. Analyse ACCPL shareholder distribution to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/E Ratio
16.94
Current Price
₹
EPS (TTM)
₹8.48
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
53.85
Sector Median
27.53
Sector Rank
#11 of 192
Sector Percentile
5.7%
ACCPL P/E Ratio — Valuation Signal & Historical Context
Accretion Pharmaceuticals P/E 16.94 — signal: Fairly Valued. Browse Accretion Pharmaceuticals annual reports for revenue, profit, balance sheet and cash flow data.
- Trading at discount to sector average PE of 53.85
ACCPL vs Healthcare Peers — P/E Ratio Comparison
Accretion Pharmaceuticals P/E 16.94 vs Healthcare average 53.85, median 27.53 — range 1.03–1007.14.
Sector Average
53.85
Sector Median
27.53
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.44 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹68 | Low |
| Par Drugs & Chemical | PAR | 8.09 | ₹113 | Low |
| Galaxy Medicare | GML | 8.65 | ₹29 | Low |